Genetic Association of Phosphodiesterases With Human Cognitive Performance by Mark E. Gurney

Get full text

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis. by Mengshi Zhou, Rong Xu, David C Kaelber, Mark E Gurney

Get full text

Therapeutic benefits of phosphodiesterase 4B inhibition after traumatic brain injury. by Nicole M Wilson, Mark E Gurney, W Dalton Dietrich, Coleen M Atkins

Get full text

Effects of chronic inhibition of phosphodiesterase-4D on behavior and regional rates of cerebral protein synthesis in a mouse model of fragile X syndrome by Michael Rosenheck, Carrie Sheeler, Rachel Michelle Saré, Mark E. Gurney, Carolyn Beebe Smith

Get full text

Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization by QuanQiu Wang, Pamela B. Davis, Xin Qi, Shu G. Chen, Mark E. Gurney, George Perry, P. Murali Doraiswamy, Rong Xu

Get full text

A Novel PDE4D Inhibitor BPN14770 Reverses Scopolamine-Induced Cognitive Deficits via cAMP/SIRT1/Akt/Bcl-2 Pathway by Yulu Wang, Yulu Wang, Shichao Gao, Victor Zheng, Ling Chen, Ling Chen, Ling Chen, Min Ma, Shichen Shen, Jun Qu, Hanting Zhang, Hanting Zhang, Mark E. Gurney, James M. O’Donnell, Ying Xu

Get full text